38,180 reports of this reaction
15.9% of all INSULIN LISPRO reports
#1 most reported adverse reaction
BLOOD GLUCOSE INCREASED is the #1 most commonly reported adverse reaction for INSULIN LISPRO, manufactured by Eli Lilly and Company. There are 38,180 FDA adverse event reports linking INSULIN LISPRO to BLOOD GLUCOSE INCREASED. This represents approximately 15.9% of all 239,540 adverse event reports for this drug.
Patients taking INSULIN LISPRO who experience blood glucose increased should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
BLOOD GLUCOSE INCREASED is a frequently reported adverse event for INSULIN LISPRO, accounting for a significant proportion of all reports.
In addition to blood glucose increased, the following adverse reactions have been reported for INSULIN LISPRO:
The following drugs have also been linked to blood glucose increased in FDA adverse event reports:
BLOOD GLUCOSE INCREASED has been reported as an adverse event in 38,180 FDA reports for INSULIN LISPRO. This does not prove causation, but indicates an association observed in post-market surveillance data.
BLOOD GLUCOSE INCREASED accounts for approximately 15.9% of all adverse event reports for INSULIN LISPRO, making it one of the most commonly reported side effect.
If you experience blood glucose increased while taking INSULIN LISPRO, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.